Common allergy-blocking antibodies in peanut allergy
Convergent allergen-specific antibodies in food allergy
This project looks at antibodies from people with peanut allergy and after immunotherapy to learn how they stop allergic reactions and could help others with food allergies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11247507 on NIH RePORTER |
What this research studies
You might be asked to give blood or samples so researchers can isolate the antibodies your immune system makes against peanut proteins. The team will compare antibody sequences from many people to find shared, high‑affinity antibodies that target the same parts of the allergen. They will use lab tests and structural biology to see exactly where those antibodies bind and whether they block the IgE reactions that cause anaphylaxis. Findings could guide new antibody-based treatments or improve immunotherapy approaches.
Who could benefit from this research
Good fit: Ideal candidates are people with peanut allergy, especially those who have had or are considering oral immunotherapy, and who can provide blood or clinical history.
Not a fit: People without IgE‑mediated food allergies or whose reactions are due to non‑allergic food intolerances are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, this work could lead to antibody therapies or improved immunotherapy that reduce severe allergic reactions to peanuts and other foods.
How similar studies have performed: Previous work, including by these investigators, has found neutralizing antibodies after oral immunotherapy, but turning those findings into widely used therapies is still early-stage.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Patil, Sarita U — Massachusetts General Hospital
- Study coordinator: Patil, Sarita U
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.